Aclaris Therapeutics, Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.68M6.15M4.23M6.48M6.76M29.75M31.25M18.72M
Gross Profit 0.48M3.24M0.17M1.35M2.05M25.73M27.83M15.93M
Operating items
Depreciation & Amortization - Total 0.37M1.25M1.51M
Research & Development 3.49M6.51M15.34M33.48M35.80M60.84M64.17M29.34M43.81M77.81M98.38M33.59M
Selling, General & Administrative 1.77M2.03M5.33M11.80M18.95M25.76M27.83M20.53M23.62M25.13M32.41M22.20M
Other Operating Expenses -22.80M-49.15M-70.39M-132.74M21.78M7.53M29.05M16.66M-2.19M104.86M
Operating Expenses 5.26M8.53M20.67M48.57M56.04M90.93M115.28M57.39M96.48M119.61M128.61M160.65M
Operating Income -5.26M-8.53M-20.67M-48.57M-54.36M-84.78M-111.06M-50.91M-89.72M-89.85M-97.36M-141.93M
EBIT -5.26M-8.53M-20.67M-48.57M-54.36M-84.78M-111.06M-50.91M-89.72M-89.85M-97.36M-141.93M
Non-operating items
Interest & Investment Income 0.02M0.02M0.10M8.51M7.95M
Other Non Operating Income 0.10M0.49M2.07M2.68M-2.48M-0.42M-1.14M2.95M8.51M
Non Operating Income 0.10M0.49M2.07M2.68M-2.48M-0.42M-1.14M2.95M8.51M9.87M
Net income details
EBT -5.24M-8.52M-20.56M-48.08M-70.35M-82.10M-113.54M-51.34M-90.86M-86.91M-88.85M-132.06M
Tax Provisions -1.83M-0.18M-0.37M
Profit After Tax -5.24M-8.52M-20.56M-48.08M-68.52M-132.74M-161.35M-51.15M-90.86M-86.91M-88.48M-132.06M
Income from Continuing Operations -5.24M-8.52M-20.56M-48.08M-68.52M-82.10M-113.54M-51.15M-90.86M-86.91M-88.48M-132.06M
Consolidated Net Income -5.24M-8.52M-20.56M-48.08M-18.06M-50.63M-47.81M0.14M-90.86M-86.91M-88.48M-132.06M
Income towards Parent Company -5.24M-8.52M-20.56M-48.08M-18.06M-50.63M-47.81M0.14M-90.86M-86.91M-88.48M-132.06M
Preferred Dividend Payments 1.74M2.05M2.57M
Net Income towards Common Stockholders -6.98M-10.57M-23.13M-48.08M-68.52M-50.63M-47.81M0.14M-90.86M-86.91M-88.48M-132.06M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 20.16M21.43M30.83M40.94M41.39M42.92M61.23M66.68M70.84M71.43M
Shares Outstanding (Diluted Average) 41.32M42.54M56.73M65.21M69.81M77.30M
EBITDA -5.23M-8.53M-20.71M-48.20M-68.50M-132.56M-161.35M-51.04M-91.00M-87.58M-87.69M-131.86M
Tax Rate 0.00M0.00M0.00M